AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
A NEW PROGNOSTIC SCORE FOR SURVIVAL OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA TREATED WITH INTERFERON-ALPHA
Authors: HASFORD J PFIRRMANN M HEHLMANN R ALLAN NC BACCARANI M KLUINNELEMANS JC ALIMENA G STEEGMANN JL ANSARI H
Citation: J. Hasford et al., A NEW PROGNOSTIC SCORE FOR SURVIVAL OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA TREATED WITH INTERFERON-ALPHA, Journal of the National Cancer Institute, 90(11), 1998, pp. 850-858
DETECTION AND MONITORING OF TRISOMY-8 BY FLUORESCENCE IN-SITU HYBRIDIZATION IN ACUTE MYELOID-LEUKEMIA - A MULTICENTRIC STUDY
Authors: CUNEO A BIGONI R ROBERTI MG BARDI A RIGOLIN GM PIVA N MANCINI M NANNI M ALIMENA G MECUCCI C MATTEUCCI C LASTARZA R BERNASCONI P CAVIGLIANO P GENINI E ZACCARIA A TESTONI N CARBONI C CASTOLDI G
Citation: A. Cuneo et al., DETECTION AND MONITORING OF TRISOMY-8 BY FLUORESCENCE IN-SITU HYBRIDIZATION IN ACUTE MYELOID-LEUKEMIA - A MULTICENTRIC STUDY, Haematologica, 83(1), 1998, pp. 21-26
POSTPARTUM FVIII-C INHIBITOR - SUCCESSFUL TREATMENT WITH RFVIIA CONCENTRATE AND HIGH-DOSE IMMUNOGLOBULIN-G AND DEXAMETHASONE
Authors: MAZZUCCONI MG PERAINO M CHISTOLINI A BIZZONI L BERNASCONI S ALIMENA G MORANO G GIORGI A RUSSO MR
Citation: Mg. Mazzucconi et al., POSTPARTUM FVIII-C INHIBITOR - SUCCESSFUL TREATMENT WITH RFVIIA CONCENTRATE AND HIGH-DOSE IMMUNOGLOBULIN-G AND DEXAMETHASONE, Thrombosis research, 91(3), 1998, pp. 44-44
USE OF DUAL-COLOR INTERPHASE-FISH TECHNIQUE AT DIAGNOSIS, AT RELAPSE AND DURING THE FOLLOW-UP OF INV(16) AML PATIENTS
Authors: CEDRONE M MANCINI W NANNI M DECUIA MR PETIT MC BOSLY A MICHAUX JL SELLESLAG D BRAMA M ANGELOZZI AL MECUCCI C ALIMENA G HAGEMEIJER A
Citation: M. Cedrone et al., USE OF DUAL-COLOR INTERPHASE-FISH TECHNIQUE AT DIAGNOSIS, AT RELAPSE AND DURING THE FOLLOW-UP OF INV(16) AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 98-98
ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC) - A COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: MONTEFUSCO E PETTI MC ALIMENA G LATAGLIATA R CELESTI F CAPRIA S AMADORI S AVVISATI G MANDELLI F
Citation: E. Montefusco et al., ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC) - A COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA, Annals of oncology, 8(2), 1997, pp. 175-179
LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - A 3RD FOLLOW-UP OF THE 4TH INTERNATIONAL WORKSHOP ON CHROMOSOMES IN LEUKEMIA
Authors: BLOOMFIELD CD SHUMA C REGAL L PHILIP PP HOSSFELD DK HAGEMEIJER AM GARSON OM PETERSON BA SAKURAI M ALIMENA G BERGER R ROWLEY JD RUUTU T MITELMAN F DEWALD GW SWANSBURY J
Citation: Cd. Bloomfield et al., LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - A 3RD FOLLOW-UP OF THE 4TH INTERNATIONAL WORKSHOP ON CHROMOSOMES IN LEUKEMIA, Cancer, 80(11), 1997, pp. 2191-2198
NEW PROGNOSTIC SCORE FOR CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH INTERFERON-ALPHA EVALUATED FROM A COLLABORATIVE METAANALYSIS BASED ON INDIVIDUAL PATIENT DATA
Authors: HASFORD J PFIRRMANN M HEHLMANN R ALLAN NC BACCARANI M KLUINNELEMANS JC ALIMENA G ANSARI H
Citation: J. Hasford et al., NEW PROGNOSTIC SCORE FOR CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH INTERFERON-ALPHA EVALUATED FROM A COLLABORATIVE METAANALYSIS BASED ON INDIVIDUAL PATIENT DATA, Blood, 90(10), 1997, pp. 2301-2301
CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE IN PH-POSITIVE CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON
Authors: ALIMENA G LAZZARINO M MORRA E MANCINI M CEDRONE M MONTEFUSCO E MERANTE S MELONI G BERNASCONI P RONDINELLI MB BERNASCONI C MANDELLI F
Citation: G. Alimena et al., CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE IN PH-POSITIVE CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON, Leukemia, 10(4), 1996, pp. 615-618
2 BCR-ABL JUNCTION PEPTIDES BIND HLA-A3 MOLECULES AND ALLOW SPECIFIC INDUCTION OF HUMAN CYTOTOXIC T-LYMPHOCYTES
Authors: GRECO G FRUCI D ACCAPEZZATO D BARNABA V NISINI R ALIMENA G MONTEFUSCO E VIGNETI E BUTLER R TANIGAKI N TOSI R
Citation: G. Greco et al., 2 BCR-ABL JUNCTION PEPTIDES BIND HLA-A3 MOLECULES AND ALLOW SPECIFIC INDUCTION OF HUMAN CYTOTOXIC T-LYMPHOCYTES, Leukemia, 10(4), 1996, pp. 693-699
CLINICAL RELEVANCE OF RESIDUAL DISEASE MONITORING BY POLYMERASE CHAIN-REACTION IN PATIENTS WITH ALL-1 AF-4 POSITIVE-ACUTE LYMPHOBLASTIC-LEUKEMIA/
Authors: CIMINO G ELIA L RIVOLTA A RAPANOTTI MC ROSSI V ALIMENA G ANNINO L CANAANI E LOCOCO F BIONDI A
Citation: G. Cimino et al., CLINICAL RELEVANCE OF RESIDUAL DISEASE MONITORING BY POLYMERASE CHAIN-REACTION IN PATIENTS WITH ALL-1 AF-4 POSITIVE-ACUTE LYMPHOBLASTIC-LEUKEMIA/, British Journal of Haematology, 92(3), 1996, pp. 659-664
ACUTE MYELOID LEUKEMIAS M2 POTENTIALLY MISDIAGNOSED AS M3 VARIANT FRENCH-AMERICAN-BRITAIN (FAB) SUBTYPE - A TRANSITIONAL FORM
Authors: FENU S CARMINI D MANCINI F GUGLIELMI C ALIMENA G RICCIONI R BARSOTTI P MANCINI M AVVISATI G MANDELLI F
Citation: S. Fenu et al., ACUTE MYELOID LEUKEMIAS M2 POTENTIALLY MISDIAGNOSED AS M3 VARIANT FRENCH-AMERICAN-BRITAIN (FAB) SUBTYPE - A TRANSITIONAL FORM, Leukemia & lymphoma, 18, 1995, pp. 49
ACUTE-LEUKEMIA PRESENTING A VARIANT PH CHROMOSOME WITH P190 EXPRESSION, DUP 3Q AND -7, DEVELOPED AFTER MALIGNANT-LYMPHOMA TREATED WITH ALKYLATING-AGENTS AND TOPOISOMERASE-II INHIBITORS
Authors: ALIMENA G CEDRONE M NANNI M DECUIA MR LOCOCO F DESANCTIS V CIMINO G MANCINI M
Citation: G. Alimena et al., ACUTE-LEUKEMIA PRESENTING A VARIANT PH CHROMOSOME WITH P190 EXPRESSION, DUP 3Q AND -7, DEVELOPED AFTER MALIGNANT-LYMPHOMA TREATED WITH ALKYLATING-AGENTS AND TOPOISOMERASE-II INHIBITORS, Leukemia, 9(9), 1995, pp. 1483-1486
COMBINED CYTOGENETIC, FISH AND MOLECULAR ANALYSIS IN ACUTE PROMYELOCYTIC LEUKEMIA AT DIAGNOSIS AND IN COMPLETE REMISSION
Authors: MANCINI M NANNI M CEDRONE M DIVERIO D AVVISATI G RICCIONI R DECUIA MR FENU S ALIMENA G
Citation: M. Mancini et al., COMBINED CYTOGENETIC, FISH AND MOLECULAR ANALYSIS IN ACUTE PROMYELOCYTIC LEUKEMIA AT DIAGNOSIS AND IN COMPLETE REMISSION, British Journal of Haematology, 91(4), 1995, pp. 878-884
INTERLEUKIN-3 PRIMING IN ACUTE MYELOID-LEUKEMIA PATIENTS
Authors: TAFURI A DEFELICE L GOODACRE A FENU S PETRUCCI MT VALENTINI T ALIMENA G PETTI MC MELONI G MANDELLI F ANDREEFF M
Citation: A. Tafuri et al., INTERLEUKIN-3 PRIMING IN ACUTE MYELOID-LEUKEMIA PATIENTS, British Journal of Haematology, 91(1), 1995, pp. 234-244
DETECTION OF HOMOZYGOUS DELETIONS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR (P16) GENE IN ACUTE LYMPHOBLASTIC-LEUKEMIA AND ASSOCIATION WITH ADVERSE PROGNOSTIC FEATURES
Authors: FIZZOTTI M CIMINO G PISEGNA S ALIMENA G QUARTARONE C MANDELLI F PELICCI PG LOCOCO F
Citation: M. Fizzotti et al., DETECTION OF HOMOZYGOUS DELETIONS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR (P16) GENE IN ACUTE LYMPHOBLASTIC-LEUKEMIA AND ASSOCIATION WITH ADVERSE PROGNOSTIC FEATURES, Blood, 85(10), 1995, pp. 2685-2690
APPLICATION OF FLUORESCENCE IN-SITU HYBRIDIZATION IN DEFINING A COMPLEX T(9-21-22) PH FORMATION
Authors: MANCINI M NANNI M CEDRONE M DECUIA MR RONDINELLI MB MALAGNINO F ALIMENA G
Citation: M. Mancini et al., APPLICATION OF FLUORESCENCE IN-SITU HYBRIDIZATION IN DEFINING A COMPLEX T(9-21-22) PH FORMATION, Haematologica, 79(6), 1994, pp. 536-539
LONG-TERM SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA - A 2ND FOLLOW-UP OFTHE 4TH INTERNATIONAL WORKSHOP ON CHROMOSOMES IN LEUKEMIA
Authors: SWANSBURY GJ LAWLER SD ALIMENA G ARTHUR D BERGER R VANDENBERGHE H BLOOMFIELD CD DELACHAPPELLE A DEWALD G GARSON OM HAGEMEIJER A MITELMAN F ROWLEY JD SAKURAI M
Citation: Gj. Swansbury et al., LONG-TERM SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA - A 2ND FOLLOW-UP OFTHE 4TH INTERNATIONAL WORKSHOP ON CHROMOSOMES IN LEUKEMIA, Cancer genetics and cytogenetics, 73(1), 1994, pp. 1-7
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP
Authors: CERVANTES F ROBERTSON JE ROZMAN C BACCARANI M TURA S GOMEZ GA BRAUN TJ CLARKSON BD PEREIRA A ZACCARIA A ZUFFA E MANDELLI F ALIMENA G MONTEFUSCO E RUSSO D FANIN R GRIGNANI F MARTELLI MF MORRA E BERNASCONI C CAJOZZO A PERONA G AMBROSETTI A LEONI P LOMBARDO M DELFINI C TORLONTANO G PORCELLINI A DEMILIO A BATTISTA R LEONI F GUGLIELMO P GIUSTOLISI R DECATALDO F NOSARI A RIZZOLI V MANGONI M CARNEVALI C LISO V SPECCHIA G BAJETTA E BROCCIA G DITUCCI A BUSINCO A BRUZZESE L ABADESA A LANZI E ALBERTI A NERI A RONCO F TONATO M GRIFONI V
Citation: F. Cervantes et al., LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP, British Journal of Haematology, 87(2), 1994, pp. 293-300
CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE (BP) IN PH-INTERFERON( CHRONIC MYELOGENOUS LEUKEMIA (CML) TREATED WITH ALPHA)
Authors: ALIMENA G MORRA E LAZZARINO M MANCINI M CEDRONE M MONTEFUSCO E MERANTE S RONDINELLI MB BERNASCONI P MELONI G BERNASCONI C MANDELLI F
Citation: G. Alimena et al., CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE (BP) IN PH-INTERFERON( CHRONIC MYELOGENOUS LEUKEMIA (CML) TREATED WITH ALPHA), Blood, 84(10), 1994, pp. 10000629-10000629
PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION
Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E
Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
MANAGEMENT OF CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION AND ALPHA-2 INTERFERON - CYTOGENETIC AND CLINICAL-RESULTS
Authors: ALIMENA G MELONI G DECUIA MR RONDINELLI MB LOCOCO F MONTEFUSCO E MANCINI M PINTO R NANNI M CEDRONE M DEFABRITIIS P MANDELLI F
Citation: G. Alimena et al., MANAGEMENT OF CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION AND ALPHA-2 INTERFERON - CYTOGENETIC AND CLINICAL-RESULTS, Leukemia & lymphoma, 11, 1993, pp. 281-291
OCCURRENCE OF A KI-1-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA IN A PATIENT WITH PH POSITIVE CHRONIC MYELOGENOUS LEUKEMIA SUCCESSFULLY TREATED BY ALPHA-INTERFERON
Authors: MONTEFUSCO E COCO FL BURGIO VL RONDINELLI B DIGIORGIO G MANCINI M DIVERIO D ANDRIANI A AVVISATI G ALIMENA G
Citation: E. Montefusco et al., OCCURRENCE OF A KI-1-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA IN A PATIENT WITH PH POSITIVE CHRONIC MYELOGENOUS LEUKEMIA SUCCESSFULLY TREATED BY ALPHA-INTERFERON, Leukemia, 7(11), 1993, pp. 1896-1899
Risultati: 1-25 | 26-29